Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Hybrid Closed Loop Insulin Delivery System in Hypoglycemia [NA]
This clinical trial update reports results for a hybrid closed-loop insulin delivery system studied in people with Type 1 diabetes and hypog…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus [Phase 1, Phase 2]
Clinical trial update exploring semaglutide GLP-1 agonists with degludec basal-bolus insulin in early type 1 diabetes (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PRISM for Adolescents With Type 1 Diabetes [NA]
The PRISM trial in adolescents with Type 1 Diabetes Mellitus has completed and its results have been posted (2023-09-21).
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Afrezza® Dosing Optimization Study [Phase 4]
Phase 4 trial update on Afrezza dosing optimization completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children [Phase 4]
Phase 4 trial comparing insulin glulisine to insulin aspart on breakfast postprandial glucose in prepubertal children with type 1 diabetes m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults [NA]
A completed clinical trial assessing the impact of acetaminophen on the performance of the Guardian Sensor (3) in adults with diabetes.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes [Phase 4]
Phase 4 clinical trial comparing FiAsp and Aspart during postprandial exercise in adults with type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Dapagliflozin in Physical Exercise in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating dapagliflozin in physical exercise for individuals with type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Glucose Counterregulation in Long Standing Type 1 Diabetes [NA]
A completed clinical trial from University of Pennsylvania studied glucose counterregulation in long-standing Type 1 diabetes, with results …
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D [Phase 2]
Phase 2 trial results for Glucagon Ready-to-Use (RTU) evaluating prevention of exercise-induced hypoglycemia in adults with Type 1 diabetes;…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Avoidance of Hyperglycaemia in People With Type 1 Diabetes
A completed clinical trial updating results on avoiding hyperglycemia in people with type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator [NA]
A completed clinical trial evaluating closed-loop control in adolescents with Type 1 Diabetes using heart rate as an exercise indicator. Res…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Allogeneic Transplantation of Expanded Pancreatic Islet Cells [Phase 2]
Phase 2 clinical trial update on allogeneic transplantation of expanded pancreatic islet cells for brittle Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes [Phase 2]
Phase 2 trial update on low-dose recombinant human interleukin-2 in patients recently diagnosed with Type 1 Diabetes; study status completed…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes [NA]
Clinical trial update on exercise snacks and glutamine aimed at improving glucose control in adolescents with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01) [NA]
Clinical trial update for the Protege extension long-term follow-up in subjects with Type 1 Diabetes Mellitus; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home [NA]
A completed clinical trial evaluating automated insulin delivery in pregnant patients with type 1 diabetes, including an extension to outpat…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: CGM Use in Poorly Controlled Youth With Type 1 Diabetes [NA]
Clinical trial update on continuous glucose monitoring (CGM) use in poorly controlled youth with type 1 diabetes; study completed with resul…
-
FDA approval · 2023-07-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2023-07-21FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. Insulin lispro is used…
-
FDA approval · 2023-07-21FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2023-07-21FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine [Phase 3]
A Phase 3 trial comparing SAR341402 to NovoLog in adults with type 1 diabetes also using insulin glargine has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Context Aware Data Gathering Study [NA]
A completed clinical trial focused on Type 1 Diabetes with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A [NA]
A completed clinical trial investigating glutathione metabolism in adolescents with Type 1 diabetes; results posted in 2023.